We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+478.73%
AUM
$1.41B
AUM Growth
+$93.6M
Cap. Flow
-$17.6M
Cap. Flow %
-1.25%
Top 10 Hldgs %
30.19%
Holding
271
New
14
Increased
65
Reduced
132
Closed
7

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$8.31M
2
UNH icon
UnitedHealth
UNH
+$8.16M
3
MSFT icon
Microsoft
MSFT
+$5.35M
4
CVX icon
Chevron
CVX
+$2.31M
5
OTIS icon
Otis Worldwide
OTIS
+$1.92M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 15.46%
3 Financials 9.31%
4 Communication Services 8.19%
5 Consumer Staples 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICSH icon
76
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.13B
$4.24M 0.3%
83,862
-11,135
-12% -$563K
LOW icon
77
Lowe's Companies
LOW
$125B
$4.18M 0.3%
25,220
-100
-0.4% -$15.4K
IEF icon
78
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$4.12M 0.29%
33,825
-1,800
-5% -$220K
ZTS icon
79
Zoetis
ZTS
$30.4B
$4.11M 0.29%
24,855
-970
-4% -$149K
CCI icon
80
Crown Castle
CCI
$32.1B
$3.9M 0.28%
23,410
-1,750
-7% -$289K
LIN icon
81
Linde
LIN
$226B
$3.8M 0.27%
15,960
-795
-5% -$193K
SHW icon
82
Sherwin-Williams
SHW
$89.8B
$3.77M 0.27%
16,218
RTX icon
83
RTX Corp
RTX
$301B
$3.76M 0.27%
65,386
-688
-1% -$41.9K
EW icon
84
Edwards Lifesciences
EW
$51.7B
$3.66M 0.26%
45,834
-1,920
-4% -$150K
VTI icon
85
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$3.64M 0.26%
21,358
-290
-1% -$48.8K
AMGN icon
86
Amgen
AMGN
$222B
$3.43M 0.24%
13,498
-140
-1% -$34.7K
LLY icon
87
Eli Lilly
LLY
$1.06T
$3.31M 0.23%
22,325
-900
-4% -$139K
BLK icon
88
Blackrock
BLK
$176B
$3.3M 0.23%
5,857
-140
-2% -$79.9K
WFC icon
89
Wells Fargo
WFC
$264B
$3.28M 0.23%
139,455
+1,583
+1% +$39K
VB icon
90
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$3.19M 0.23%
20,743
-2,590
-11% -$398K
VRTX icon
91
Vertex Pharmaceuticals
VRTX
$126B
$3.11M 0.22%
11,439
+1,682
+17% +$464K
CVX icon
92
Chevron
CVX
$366B
$2.94M 0.21%
40,870
-27,432
-40% -$2.31M
SPGI icon
93
S&P Global
SPGI
$120B
$2.91M 0.21%
8,075
-396
-5% -$140K
ATVI
94
DELISTED
Activision Blizzard
ATVI
$2.9M 0.21%
35,890
+14,186
+65% +$1.15M
NKE icon
95
Nike
NKE
$61.9B
$2.85M 0.2%
22,722
+761
+3% +$81.7K
ROP icon
96
Roper Technologies
ROP
$39.8B
$2.77M 0.2%
7,000
-485
-6% -$202K
TJX icon
97
TJX Companies
TJX
$178B
$2.76M 0.2%
49,530
-3,655
-7% -$197K
TGT icon
98
Target
TGT
$68B
$2.62M 0.19%
16,614
-650
-4% -$89.2K
ADP icon
99
Automatic Data Processing
ADP
$108B
$2.55M 0.18%
18,249
FIS icon
100
Fidelity National Information Services
FIS
$22.1B
$2.5M 0.18%
16,999
-85
-0.5% -$12.3K

Similar funds

Chesley Taft & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Chesley Taft & Associates held 271 positions worth $1.41B, up 7.1% from $1.31B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Chesley Taft & Associates's Q3 2020 filing shows 14 new, 65 increased, 132 reduced and 7 closed positions. Its largest new stake was Walmart Inc: 52,551 shares worth $2.45M. The largest sale was Ecolab, an estimated $8.31M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Chesley Taft & Associates's largest Q3 2020 buy was Walmart Inc: 52,551 shares worth $2.45M.
  • Chesley Taft & Associates added most to Verizon in Q3 2020, an estimated $8.24M increase.
  • Chesley Taft & Associates's biggest Q3 2020 reduction was Ecolab, cutting an estimated $8.31M.
  • Chesley Taft & Associates fully exited Otis Worldwide in Q3 2020, selling an estimated $1.92M.
  • Chesley Taft & Associates's ten largest holdings make up 30% of its $1.41B portfolio in Q3 2020.
  • Chesley Taft & Associates opened 14 new positions and closed 7 in Q3 2020.
  • Chesley Taft & Associates's portfolio value rose 7.1% quarter-over-quarter to $1.41B.

Based on Chesley Taft & Associates's 13F filing for Q3 2020, filed 8 Oct 2020.